ISL
PFE icon

Ingalls & Snyder LLC’s Pfizer PFE Stock Holding History

Ingalls & Snyder LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-58,400
Closed -$1.48M – 483
2025
Q1 		$1.48M Hold
58,400
– – 0.05% 182
2024
Q4 		$1.55M Hold
58,400
– – 0.06% 167
2024
Q3 		$1.69M Hold
58,400
– – 0.07% 169
2024
Q2 		$1.63M Sell
58,400
-700
-1% -$19.3K 0.07% 164
2024
Q1 		$1.64M Buy
59,100
+33,000
+126% +$916K 0.07% 164
2023
Q4 		$751K Buy
+26,100
New +$789K 0.03% 241

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ingalls & Snyder LLC's PFE Position: Q2 2026 in Review

Ingalls & Snyder LLC increased its Pfizer (PFE) stake by 3.1% in Q2 2026, buying an estimated $582K and bringing the position to 730,345 shares worth $17.6M. The position accounts for 0.48% of the portfolio, ranked #43.

Ingalls & Snyder LLC first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $34.2M in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ingalls & Snyder LLC held 730,345 shares of Pfizer worth $17.6M as of Q2 2026.
  • Ingalls & Snyder LLC bought 22,248 Pfizer shares in Q2 2026, an estimated $582K.
  • Pfizer made up 0.48% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #43 holding.
  • Ingalls & Snyder LLC first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Ingalls & Snyder LLC's Pfizer position peaked at $34.2M in Q4 2021.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.